Announced Thu, 25 Jun · 11:38 IST
NPPA demand notice for alleged overcharging of scheduled formulations
Regulatory & Legal View source PDF
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹2370.00
prior close
₹2380.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1+0.1-0.2-0.5+3.4+2.5+1.6+1.6+1.6+3.6+7.8——
Up moveDown movePending
AI summary
GSK Pharmaceuticals received a demand notice dated 24 June 2026 from the National Pharmaceutical Pricing Authority (NPPA) for alleged overcharging of scheduled formulations. Total demand is about Rs 3.54 crore, comprising Rs 1.22 crore as alleged overcharge and Rs 2.31 crore as interest. The company states no impact on financial operations and will file an appeal against the demand order.
Likely market impact
Small demand relative to company size; firm will appeal; no immediate hit to financials or operations stated.